Zydus Group

Zydus Lifesciences, formerly known as Cadila Healthcare, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad. The company operates as a fully integrated healthcare provider with extensive capabilities in the development and manufacturing of generic drugs, active pharmaceutical ingredients (APIs), and complex biologics. Zydus gained significant global recognition for developing ZyCoV-D, the world's first plasmid DNA vaccine for COVID-19, showcasing its advanced vaccine research platform. Its innovative pipeline is highlighted by Saroglitazar, a first-in-class dual PPAR agonist for liver diseases, and Desidustat, an oral treatment for anemia in chronic kidney disease. With a strong commercial presence in India and the United States, Zydus focuses on therapeutic areas including oncology, cardiology, respiratory, and gastroenterology while continuing to expand its portfolio through biosimilars and specialty products.